Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 23Observational 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Melanoma 2

Interventions

Blood Specimen Collection 14Nivolumab 13Ipilimumab 12pembrolizumab 11trametinib 9Surveys and Questionnaires 9Gene Expression Profiling 9dabrafenib 8Biopsy 6Specimen Handling 5Immunotherapy 5Immunohistochemistry 5Amplified Fragment Length Polymorphism Analysis 4encorafenib 3binimetinib 3atezolizumab 3Restraint, Physical 3Quality of Life 3Polymerase Chain Reaction 3Introns 3Flow Cytometry 3Drug Therapy 3Data Collection 3tremelimumab 2pimonidazole 2cobimetinib 2aldesleukin 2Watchful Waiting 2Vemurafenib 2Therapeutics 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Melanoma × Interferon-alpha × Clear all
NCT00897520 2017-05-19

Biomarkers in Patients With High-Risk Melanoma Receiving High-Dose Interferon Therapy

Eastern Cooperative Oncology Group

Completed
40 enrolled
Dermatologic

Melanoma

NCT02074605 2014-02-28

Cognitive Effects of Interferon in Patients With Melanoma

University of Arizona

Completed
36 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡